
Sign up to save your podcasts
Or


In this episode of CTSNet’s flagship podcast, editor in chief Joel Dunning interviews Dr. Michael Mack. Dr. Mack, of Baylor Healthcare System, is the first author of the PARTNER 3 trial, which recently published its five-year results. They talk about the outcomes of the trial and what they mean for the future of TAVR.
Items Mentioned
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
By CTSNet4.6
88 ratings
In this episode of CTSNet’s flagship podcast, editor in chief Joel Dunning interviews Dr. Michael Mack. Dr. Mack, of Baylor Healthcare System, is the first author of the PARTNER 3 trial, which recently published its five-year results. They talk about the outcomes of the trial and what they mean for the future of TAVR.
Items Mentioned
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

91,297 Listeners

43,837 Listeners

134 Listeners

504 Listeners

1,309 Listeners

906 Listeners

1,468 Listeners

2,455 Listeners

113,121 Listeners

30 Listeners

8,043 Listeners

94 Listeners

437 Listeners

29,272 Listeners

3 Listeners